Loading...
Loading...
Acceleron Pharma
XLRN today announced
that it has commenced an underwritten public offering of $100 million of
its common stock. All of the shares in the offering are to be sold by
Acceleron.
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in